T. Rowe Price Associates
GCO icon

T. Rowe Price Associates’s Genesco GCO Stock Holding History

T. Rowe Price Associates’s Portfolio GCO Stock Details GCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$533K Buy
18,359
+2,653
+17% +$76.3K ﹤0.01% 2426
2025
Q4 		$390K Hold
15,706
– – ﹤0.01% 2503
2025
Q3 		$456K Buy
15,706
+903
+6% +$24.8K ﹤0.01% 2398
2025
Q2 		$292K Sell
14,803
-129
-0.9% -$2.7K ﹤0.01% 2545
2025
Q1 		$318K Buy
14,932
+540
+4% +$18.8K ﹤0.01% 2445
2024
Q4 		$616K Buy
14,392
+650
+5% +$21.4K ﹤0.01% 2196
2024
Q3 		$374K Buy
13,742
+348
+3% +$9.66K ﹤0.01% 2377
2024
Q2 		$347K Buy
13,394
+82
+0.6% +$2.15K ﹤0.01% 2354
2024
Q1 		$375K Buy
13,312
+316
+2% +$9.12K ﹤0.01% 2326
2023
Q4 		$458K Buy
12,996
+241
+2% +$7.41K ﹤0.01% 2215
2023
Q3 		$394K Buy
12,755
+1,936
+18% +$54.9K ﹤0.01% 2224
2023
Q2 		$271K Buy
10,819
+900
+9% +$26.1K ﹤0.01% 2412
2023
Q1 		$366K Buy
9,919
+826
+9% +$36.2K ﹤0.01% 2248
2022
Q4 		$418K Buy
9,093
+212
+2% +$9.62K ﹤0.01% 2215
2022
Q3 		$350K Sell
8,881
-1,168
-12% -$62.4K ﹤0.01% 2308
2022
Q2 		$502K Sell
10,049
-13
-0.1% -$779 ﹤0.01% 2221
2022
Q1 		$640K Buy
10,062
+282
+3% +$18.4K ﹤0.01% 2233
2021
Q4 		$628K Sell
9,780
-255
-3% -$16.2K ﹤0.01% 2285
2021
Q3 		$579K Sell
10,035
-2,600
-21% -$155K ﹤0.01% 2308
2021
Q2 		$805K Sell
12,635
-4,138
-25% -$224K ﹤0.01% 2161
2021
Q1 		$797K Sell
16,773
-4,328
-21% -$186K ﹤0.01% 2166
2020
Q4 		$635K Buy
21,101
+4,500
+27% +$115K ﹤0.01% 2137
2020
Q3 		$358K Hold
16,601
– – ﹤0.01% 2219
2020
Q2 		$360K Sell
16,601
-2
-0% -$37 ﹤0.01% 2185
2020
Q1 		$221K Buy
16,603
+4,486
+37% +$151K ﹤0.01% 2287
2019
Q4 		$581K Buy
12,117
+5,338
+79% +$221K ﹤0.01% 2103
2019
Q3 		$271K Buy
6,779
+16
+0.2% +$617 ﹤0.01% 2319
2019
Q2 		$286K Buy
6,763
+40
+0.6% +$1.77K ﹤0.01% 2311
2019
Q1 		$306K Buy
6,723
+60
+0.9% +$2.75K ﹤0.01% 2284
2018
Q4 		$295K Buy
6,663
+36
+0.5% +$1.55K ﹤0.01% 2289
2018
Q3 		$312K Buy
6,627
+116
+2% +$5.06K ﹤0.01% 2344
2018
Q2 		$258K Sell
6,511
-4,571
-41% -$195K ﹤0.01% 2392
2018
Q1 		$450K Sell
11,082
-2,962
-21% -$110K ﹤0.01% 2125
2017
Q4 		$456K Buy
+14,044
New +$386K ﹤0.01% 2120
2017
Q2 		– Sell
-408,900
Closed -$22.7M – 2565
2017
Q1 		$22.7M Sell
408,900
-13,380
-3% -$797K ﹤0.01% 1107
2016
Q4 		$26.2M Sell
422,280
-42,420
-9% -$2.59M 0.01% 1039
2016
Q3 		$25.3M Buy
464,700
+459,140
+8,258% +$29M 0.01% 1046
2016
Q2 		$358K Hold
5,560
– – ﹤0.01% 2098
2016
Q1 		$402K Hold
5,560
– – ﹤0.01% 2064
2015
Q4 		$316K Buy
5,560
+60
+1% +$3.47K ﹤0.01% 2135
2015
Q3 		$314K Hold
5,500
– – ﹤0.01% 2126
2015
Q2 		$363K Hold
5,500
– – ﹤0.01% 2132
2015
Q1 		$392K Sell
5,500
-960
-15% -$69.6K ﹤0.01% 2066
2014
Q4 		$495K Buy
6,460
+60
+0.9% +$4.56K ﹤0.01% 1960
2014
Q3 		$478K Hold
6,400
– – ﹤0.01% 1957
2014
Q2 		$526K Hold
6,400
– – ﹤0.01% 1934
2014
Q1 		$477K Hold
6,400
– – ﹤0.01% 1935
2013
Q4 		$468K Hold
6,400
– – ﹤0.01% 1937
2013
Q3 		$420K Sell
6,400
-3,000
-32% -$205K ﹤0.01% 1960
2013
Q2 		$630K Buy
+9,400
New +$605K ﹤0.01% 1785

Other funds holding GCO

Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
F1I
Fund 1 Investments Rincon, Puerto Rico $872M AUM 50.95% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

T. Rowe Price Associates's GCO Position: Q1 2026 in Review

T. Rowe Price Associates increased its Genesco (GCO) stake by 17% in Q1 2026, buying an estimated $76.3K and bringing the position to 18,359 shares worth $533K. The position accounts for ﹤0.01% of the portfolio, ranked #2426.

T. Rowe Price Associates first reported a position in GCO in Q2 2013 and has held it in 50 quarters since. The position peaked at $26.2M in Q4 2016. 129 funds tracked by Wall St. Rank hold GCO as of Q1 2026.

  • T. Rowe Price Associates held 18,359 shares of Genesco worth $533K as of Q1 2026.
  • T. Rowe Price Associates bought 2,653 Genesco shares in Q1 2026, an estimated $76.3K.
  • Genesco made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q1 2026, its #2426 holding.
  • T. Rowe Price Associates first reported a position in Genesco in Q2 2013 and has held it in 50 quarters since.
  • T. Rowe Price Associates's Genesco position peaked at $26.2M in Q4 2016.
  • 129 funds tracked by Wall St. Rank held Genesco as of Q1 2026.

Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.